Advertisement

Pituitary

, Volume 8, Issue 1, pp 3–6 | Cite as

The Epidemiology of Prolactinomas

  • Antonio Ciccarelli
  • Adrian F. Daly
  • Albert Beckers
Article

Abstract

Prolactin-secreting tumors (prolactinomas), the most frequently occurring pituitary tumor, have a frequency that varies with age and sex. They occur most frequently in females aged 20 to 50 years old, at which time the female-to-male ratio is approximately 10:1. In the pediatric-adolescent age group, prolactinomas have a prevalence of 100/million population, and account for less than 2% of all intracranial tumors. Prolactinomas occur in approximately 30% of patients with multiple endocrine neoplasia type 1 and in this setting, they may be more aggressive than their sporadic counterparts. Patients with Carney complex or McCune-Albright syndrome may exhibit hyperprolactinemia due to a pituitary tumor derived from somatomammotropic cells that secrete both growth hormone and prolactin. Few familial cases of prolactinoma unrelated to MEN-1 are reported in literature.

Key Words

prolactin prolactinoma pituitary tumor inherited neoplasm epidemiology 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Burrow GN, Wortzman G, Rewcastle NB, Holgate RC, Kovacs K. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 1981;304(3):156–158.PubMedCrossRefGoogle Scholar
  2. 2.
    Molitch ME, Russell EJ. The pituitary incidentaloma. Ann Intern Med 1990;112(12):925–931.PubMedGoogle Scholar
  3. 3.
    Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 1994;120(10):817–820.PubMedGoogle Scholar
  4. 4.
    Colao A, Lombardi G. Growth-hormone and prolactin excess. Lancet 1998;352:1455–1461.CrossRefPubMedGoogle Scholar
  5. 5.
    Vance ML, Thorner MO. Prolactin: Hyperprolactinemic syndromes and management. In: DeGroot LJ, ed. Textbook of Endocrinology, 2nd edition. Philadelphia, London, Toronto, Mexico City, Rio de Janerio, Sydney, Tokyo, Hong Kong:WB Saunders Company 1989;408–418.Google Scholar
  6. 6.
    Arafah BM, Nasrallah MP. Pituitary tumors. pathophysiology, clinical manifestations and management. Endocr Relat Cancer 2001;8(4):287–305.CrossRefPubMedGoogle Scholar
  7. 7.
    Mindermann T, Wilson CB. Age-related and gender-related occurrence of pituitary adenomas. Clin Endocrinol (Oxf) 1994;41(3):359–364.Google Scholar
  8. 8.
    Davis JR, Farrell WE, Clayton RN. Pituitary tumours. Reproduction 2001;121(3):363–371.CrossRefPubMedGoogle Scholar
  9. 9.
    Beckers A, Adam C, Ciccarelli A, Rixhon M, Daly A, Petrossians P, Stevenaert A. Approaching the true prevalence of pituitary tumors. ENEA Congress 2004; Abstract O1.1: 23. www.eneassoc.org/abstracts.pdf (accessed October 28th, 2005).Google Scholar
  10. 10.
    Calle-Rodriguez RD, Giannini C, Scheithauer BW et al. Prolactinomas in male and female patients: A comparative clinicopathologic study. Mayo Clin Proc 1998;73:1046–1052.Google Scholar
  11. 11.
    Delgrange E, Trouillas J, Maiter D, Donckier J, Tourniaire J. Sex-related difference in the growth of prolactinomas: A clinical and proliferation marker study. J Clin Endocrinol Metab 1997;82:2102–2107.CrossRefPubMedGoogle Scholar
  12. 12.
    Kovacs K, Ryan N, Horvath E, Singer W, Ezrin C. Pituitary adenomas in old age. J Gerontol 1980;35(1):16–22.PubMedGoogle Scholar
  13. 13.
    McComb DJ, Ryan N, Horvath E, Kovacs K. Subclinical adenomas of the human pituitary. New light on old problems. Arch Pathol Lab Med 1983;107(9):488–491.PubMedGoogle Scholar
  14. 14.
    Cohen DL, Bevan JS, Adams CB. The presentation and management of pituitary tumours in the elderly. Age Ageing 1989;18(4):247–252.PubMedGoogle Scholar
  15. 15.
    Benbow SJ, Foy P, Jones B, Shaw D, McFarlane IA. Pituitary tumors presenting in the elderly: management and outcome. Clin Endocrinol 1997;46:657–660.CrossRefGoogle Scholar
  16. 16.
    Turner HE, Christopher BTA, Wass JAH. Pituitary tumors in the elderly: a 20 year experience. Eur J Endocrinol 1999;140:383–389.PubMedGoogle Scholar
  17. 17.
    Mindermann T, Wilson CB. Pituitary adenomas in childhood and adolescence. J Pediatr Endocrinol Metab 1995;8:79–83.PubMedGoogle Scholar
  18. 18.
    Colao A, Loche S, Cappa M et al. Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up. J Clin Endocrinol Metab 1998;83:2777–2780.PubMedGoogle Scholar
  19. 19.
    Lafferty AR, Chrousos GP. Pituitary tumors in children and adolescents. J Clin Endocrinol Metab 1999;84:4317–4323.CrossRefPubMedGoogle Scholar
  20. 20.
    Obuobie K, Mullik V, Jones C et al. McCune-Albright Syndrome: Growth hormone dynamics in pregnancy. J Clin Endocrinol Metab 2001;86:2456–2458.CrossRefPubMedGoogle Scholar
  21. 21.
    Bhansali A, Sharma BS, Sreenivasulu P, Singh P, Vashisth RK, Dash RJ. Acromegaly with fibrous dysplasia: McCune-Albright syndrome. Endocrine J 2003;50:793–799.CrossRefGoogle Scholar
  22. 22.
    Petrossians P, De Herder W, Kwekkeboom D, Lamberigts G, Stevenaert A, Beckers A. Malignant Prolactinoma discovered by D2 receptor imaging. J Clin Endocrinol Metab 2000;85(1):398–401.CrossRefPubMedGoogle Scholar
  23. 23.
    Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001;86(12):5658–5671.CrossRefPubMedGoogle Scholar
  24. 24.
    Verges B, Boureille F, Goudet P, et al. Pituitary disease in MEN type 1 (MEN1): Data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab 2002;87(2):457–465.CrossRefPubMedGoogle Scholar
  25. 25.
    Burgess JR, Shepherd JJ, Parameswaran V, Hoffman L, Greenaway TM. Prolactinomas in a large kindred with multiple endocrine neoplasia type 1: clinical features and inheritance pattern. J Clin Endocrinol Metab 1996;81(5):1841–1845.CrossRefPubMedGoogle Scholar
  26. 26.
    Knudson AG. Hereditary cancer: two hits revisited. J Cancer Res Clin Oncol 1996;122(3):135–140.CrossRefPubMedGoogle Scholar
  27. 27.
    Simonds WF, James-Newton LA, Agarwal SK, et al. Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine 2002;81(1):1–26.CrossRefPubMedGoogle Scholar
  28. 28.
    Hao W, Skarulis MC, Simonds WF, et al. Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma. J Clin Endocrinol Metab 2004;89(8):3776–3784.CrossRefPubMedGoogle Scholar
  29. 29.
    Petty EM, Green JS, Marx SJ, Taggart RT, Farid N, Bale AE. Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN1Burin) to chromosome 11q: evidence for a founder effect in patients from Newfoundland. Am J Hum Genet 1994;54(6):1060–1066.PubMedGoogle Scholar
  30. 30.
    Olufemi SE, Green JS, Manickam P, et al. Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland. Hum Mutat 1998;11(4):264–269.CrossRefPubMedGoogle Scholar
  31. 31.
    Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 2001;86(9):4041–4046.CrossRefPubMedGoogle Scholar
  32. 32.
    Berezin M, Karasik A. Familial Prolactinoma. Clinical Endocrinology 1995;42:483–486.PubMedGoogle Scholar
  33. 33.
    Poncin J, Abs R, Velkeniers B, et al. Mutation analysis of the MEN1 gene in Belgian patients with Multiple Neoplasia Type 1 and related diseases. Hum Mutation 1999;13:54–60.Google Scholar
  34. 34.
    Daly AF, Jaffrain-Rea ML, Beckers A. Clinical and genetic features of familial pituitary adenomas. Horm Metab Res 2005;37(6):347–354.Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Antonio Ciccarelli
    • 1
  • Adrian F. Daly
    • 1
  • Albert Beckers
    • 1
    • 2
  1. 1.Department of Endocrinology, C.H.U. de LiègeUniversity of LiègeBelgium
  2. 2.Department of Endocrinology, C.H.U. de LiègeUniversity of LiègeLiègeBelgium

Personalised recommendations